Organogenesis

Historical price data

Organogenesis is a commercial-stage regenerative medicine company focused on delivering innovative tissue repair solutions. It has a long-standing legacy as an early MIT spin-off and holds some of the first FDA approvals for living, human-cell-based products. The company's mission is to elevate the standard of care through a portfolio of advanced wound care and surgical biologics, supported by comprehensive patient and provider programs. Its strategic direction includes expanding manufacturing capacity, as evidenced by its new Rhode Island facility, to support future growth.

A proprietary platform for delivering living human cells via a three-dimensional (3D) construct to stimulate the body's natural healing and regeneration processes.

Main competitors include large medtech firms (Smith & Nephew, Integra LifeSciences) and specialized biotechs (MiMedx, Avita Medical). Organogenesis differentiates itself through its pioneering FDA-approved living cell-based products, long-term clinical data, and its comprehensive 'Circle of Care' support ecosystem for providers and patients.